2Bab I, Gavish H, Namdar-Attar M,et al. Isolation of mitogenically active C-terminal truncated pentapeptidc of ostcogenic growth peptide from human plasma and culture medium of murine osteoblastic cells. J Peptide Res, 1999,54:08-414.
3Brager MA,Patterson MJ,Connolly JF, et al. Osteogenic growth peptide normally stimulated by blood loss and marrow ablation haslocal and systemic effects on fracture healing in rats. J Orthop Res,2000, 18(1):133-139.
4Gabet Y, Muller R, Regev E, et al. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone,2004,35(1 ) :65-73.
5Bab I, Chorev M. Osteogenic growth peptide : from concept to drug design.Biopolymers, 2002,66(1) :33-48.
6Teitelbaum SL.Bone resorption by osteoclasts. Science, 2000,289:1504-1508.
7Lacey DL,Timms E, Tan HL, et al. Osteoprotegefin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 1998,93 : 165-176.
8Takayanagi H, Juji T, Miyazaki T, et al .Suppression of arthritic bone destruction by adenovirus- mediated csk gene gene transfer to synoviocytes and osteoclasts. J Clin Invest,1999, 94(2): 137- 145
9Takahashi N, Yamana H, Yoshiki S.Osteoclast- like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology, 1998, 122: 1373- 1382
10Armstrong AP, Tometsko ME, Glaccum M, et al. A RANK/TRAF6 - dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.J Biol Chem, 2002, 277(46) :44347- 44356
